Michael A. Fischbach, Ph.D.
Associate Professor
Department of Bioengineering
Department of Microbiology & Immunology
Stanford University
fischbach [at] fischbachgroup [dot] org
(650) 723-7648
Michael Fischbach is an Associate Professor in the Departments of
Bioengineering and Microbiology &
Immunology at Stanford University, an
Institute Scholar of Stanford ChEM-H, and
the director of the Stanford Microbiome
Therapies Initiative. Fischbach is a
recipient of the NIH Director's Pioneer and
New Innovator Awards, an HHMI-Simons
Faculty Scholars Award, a Fellowship for
Science and Engineering from the David and
Lucille Packard Foundation, a Medical
Research Award from the W.M. Keck
Foundation, a Burroughs Wellcome Fund
Investigators in the Pathogenesis of
Infectious Disease award, and a Glenn Award
for Research in Biological Mechanisms of
Aging. His laboratory uses a combination of
genomics and chemistry to identify and
characterize small molecules from microbes,
with an emphasis on the human
microbiome. Fischbach received his Ph.D. as
a John and Fannie Hertz Foundation Fellow
in chemistry from Harvard in 2007, where he
studied the role of iron acquisition in
bacterial pathogenesis and the biosynthesis
of antibiotics. After two years as an
independent fellow at Massachusetts General
Hospital, Fischbach joined the faculty at
UCSF, where he founded his lab before
moving to Stanford in 2017. Fischbach is a
co-founder and director of Federation Bio
and Kelonia, a co-founder of Revolution
Medicines, a member of the scientific
advisory boards of NGM Biopharmaceuticals
and the Chan Zuckerberg Initiative, and an innovation partner at
The Column Group.